Naureen Starling, MBBS, MD

Background Dostarlimab is a humanized monoclonal antibody that binds the programmed cell death protein 1 (PD-1) receptor and blocks interaction with its ligands PD-L1 and PD-L2. The GARNE...

D. Berton ;

T. Andre ;

G. Curigliano ;

H. Arkenau ;

J. Trigo ;

S. Ellard ;

V. Moreno ;

C. Abdeddaim ;

A. Anton ;

S. Kumar ;

W. Guo ;

E. Im ;

Naureen Starling , MBBS, MD;

07/01/2021

Pathological primary tumour and lymph node regression following neoadjuvant chemotherapy in resectable oesophagogastric cancer: Pooled analysis of 1619 patients from two randomised trials

Background No definitive largescale data exists evaluating the role of pathologically defined regression changes within lymph nodes (LN) of resected oesophagogastric (OG) adenocarcinoma ...

Naureen Starling , MBBS, MD;

A. Athauda ;

M. Nankivell ;

S. Pritchard ;

R. Langer ;

R. Langley ;

K. Von Loga ;

I. Chau ;

David Cunningham ;

H. Grabsch ;

06/30/2022

Immunotherapy for GI Cancers in the Elderly